Plain-English translation of NCT06321757 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is studying paclitaxel-coated balloon therapy, a treatment that uses a special balloon coated with a medication to open small blocked arteries in the heart. The study focuses on real-world patients and particularly looks at whether people at high risk of bleeding can safely use a shorter course of blood-thinning medications after this procedure.
Many patients with small heart artery blockages are at higher risk of serious bleeding if they take blood thinners for long periods. This trial aims to show that the medication on the balloon works well and that high-risk patients can be treated safely with a much shorter course of blood-thinning therapy.
You will receive the coated balloon procedure as part of your regular heart care. After the procedure, you will have follow-up visits at 30 days, 6 months, and 12 months to check how you are doing. The study team will review your heart imaging in a special lab and monitor you for any complications or symptoms. The entire study lasts one year.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
Italy
Portugal
Spain